已收盘 09-03 16:00:00 美东时间
0.000
0.00%
ImmunoPrecise Antibodies (NASDAQ:HYFT) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is unchanged from the same period last year. The company
2025-12-15 21:42
MindWalk Holdings (NASDAQ:HYFT) has authorized a share repurchase program of up to 2.3M common shares. The buyback represents ~5% of the company’s 46.15M shares outstanding. The program will run from ...
2025-10-09 19:41
An Evolution in Name, Structure, and Strategy Reflecting the Company's AI-Driven Platform and Bio-Native Discovery Vision
2025-09-03 20:52
迅雷绩后上演翻倍行情!投资影石创新浮盈超50亿;OpenDoor隔夜大涨19%,此前获知名加密货币投资者买入>>
2025-08-19 19:53
ImmunoPrecise Antibodies (NASDAQ:IPA) announced on Wednesday the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies to AVS Bio for a total enterprise value of $12M. AVS Bi...
2025-08-06 20:42
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
2025-07-29 16:32
计划长期储备比特币,MFH飙涨超50%;公司获高额溢价收购,CIO大涨超24%;与甲骨文达成供电合作,BE大涨23%>>
2025-07-25 19:50
ImmunoPrecise Antibodies ( ($IPA) ) has shared an update. ImmunoPrecise Antibod...
2025-07-24 21:18